Natalizumab exposure during pregnancy in multiple sclerosis: a systematic review

J Neurol Sci. 2019 Jan 15:396:202-205. doi: 10.1016/j.jns.2018.11.026. Epub 2018 Nov 22.

Authors

Anjiao Peng¹, Xiangmiao Qiu¹, Lin Zhang¹, Xi Zhu¹, Shixu He¹, Wanlin Lai¹, Lei Chen²

Affiliations

¹ Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.
² Department of Neurology, West China Hospital, Sichuan University, Chengdu, China. Electronic address: Leilei_25@126.com.

PMID: 30502611
DOI: 10.1016/j.jns.2018.11.026

No abstract available

Keywords: Multiple sclerosis; Natalizumab; Pregnancy.

Publication types

Research Support, Non-U.S. Gov't
Systematic Review

MeSH terms

Abortion, Spontaneous / chemically induced*
Female
Humans
Immunologic Factors / adverse effects*
Immunologic Factors / therapeutic use
Multiple Sclerosis / drug therapy*
Natalizumab / adverse effects*
Pregnancy / drug effects*

Substances

Immunologic Factors
Natalizumab